Fig. 5

T-test analysis of bacterial composition at the phylum level. (a, b) Significant differences in dominant bacterial phyla between treatment groups (WA, WB, WC) and the control (WD) at days 15 and 30. TCHMC supplementation increased Bacteroidetes abundance while reducing Firmicutes, a shift often associated with improved metabolic health.